Partial Lacrimal Punctual Occlusion

NCT ID: NCT00802399

Last Updated: 2009-01-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-09-30

Study Completion Date

2008-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to describe a case series of patients with chronic dry eye submitted to partial punctual occlusion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Eye

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Partial Lacrimal Punctual Occlusion

Cauterization of the edge of all lacrimal punctum was carried out in all patients

Group Type OTHER

Partial Lacrimal Punctual Occlusion

Intervention Type PROCEDURE

Cauterization of the edge of all lacrimal punctum was carried out in all patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Partial Lacrimal Punctual Occlusion

Cauterization of the edge of all lacrimal punctum was carried out in all patients

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sin and symptom of dry eye
* Use more than 4 times a day topic lubricant for the eye

Exclusion Criteria

* Ocular diseases other than dry eye
* Use of systemic drugs
Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Sao Paulo General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ricardo Holzchuh, MD

Role: PRINCIPAL_INVESTIGATOR

Instituto do Coracao

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo

São Paulo, São Paulo, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0300/08

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.